Low expression of FBP1 is associated with the clinical stages of bladder cancer and is closely related to lower survival rates in bladder cancer patients (in whom there is more frequent urinary epithelial recurrence and metastasis) [113]. This evidence concerns the gene FBP1 and urinary bladder cancer.